Curtis L. Meinert

Curtis L. Meinert's AcademicInfluence.com Rankings

Curtis L. Meinert

Medical

#1892

World Rank

#2275

Historical Rank

#433

USA Rank

Epidemiology

#412

World Rank

#431

Historical Rank

#69

USA Rank

medical Degrees

Curtis L. Meinert

Mathematics

#6777

World Rank

#9325

Historical Rank

#1988

USA Rank

Statistics

#689

World Rank

#774

Historical Rank

#164

USA Rank

mathematics Degrees

Download Badge

Medical
Mathematics

Curtis L. Meinert's Degrees

PhD Biostatistics Johns Hopkins University
Masters Biostatistics Johns Hopkins University

Why Is Curtis L. Meinert Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Curtis Lynea Meinert was an American clinical trialist. He was a professor of epidemiology and biostatistics at Johns Hopkins Bloomberg School of Public Health. Life Meinert was born on June 30, 1934, on a farm outside Sleepy Eye, Minnesota. His parents were Mabel Eleanor Christensen and Arthur August Edward Meinert. He was raised in rural Minnesota. He completed a B.A. in psychology from the University of Minnesota in 1956. He earned a doctor of philosophy in statistics at University of Minnesota in 1964. His dissertation was titled Quantitation of the isotope displacement of immunoassay of insulin. His advisor was Richard B. McHugh.

(See a Problem?)

Curtis L. Meinert's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. (1970) (1023)
Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. (1992) (861)
Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. (1978) (598)
Clinical Trials: Design, Conduct, and Analysis (1986) (542)
Perioperative Morbidity in Patients Randomized to Epidural or General Anesthesia for Lower Extremity Vascular Surgery (1993) (529)
HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality (2014) (484)
Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. (2000) (463)
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. (2014) (406)
Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. (2014) (404)
Results at age 8 years of early intervention for low-birth-weight premature infants. The Infant Health and Development Program. (1997) (372)
Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials: The Cross Trial Safety Analysis (2008) (349)
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial (2007) (321)
Extended results of the Alzheimer’s disease anti-inflammatory prevention trial (2011) (317)
A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group. (1994) (299)
The effect of treatment on mortality in "mild" hypertension: results of the hypertension detection and follow-up program. (1982) (297)
Depressive Symptoms as Predictors of Medical Outcomes in HIV Infection (1993) (250)
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results. (1971) (243)
The effects of physical therapy on cerebral palsy. A controlled trial in infants with spastic diplegia. (1988) (228)
Double-masked Randomized Trial Comparing Alternate Combinations of Intraoperative Anesthesia and Postoperative Analgesia in Abdominal Aortic Surgery (2001) (225)
A cohort study of summary reports of controlled trials. (1990) (207)
Sertraline for the treatment of depression in Alzheimer disease. (2010) (204)
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines (1990) (194)
Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. (2007) (145)
Preliminary Report on Effects of Photocoagulation Therapy. (2018) (138)
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. (2010) (126)
Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatricians. (1989) (126)
Design of the Wegener's Granulomatosis Etanercept Trial (WGET). (2002) (118)
The refractive status and vision profile: a questionnaire to measure vision-related quality of life in persons with refractive error. (2000) (116)
Trends in National Institutes of Health Funding for Clinical Trials Registered in ClinicalTrials.gov. (2015) (113)
Human papillomavirus and cervical neoplasia: A case‐control study in Taiwan (1995) (111)
Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. (2012) (103)
Wearable activity monitors in oncology trials: Current use of an emerging technology. (2018) (100)
Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. (2007) (98)
Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. Hypertension Detection and Follow-up Program Cooperative Group. (1988) (94)
Alzheimer's Disease Anti-Inflammatory Prevention Trial: Design, methods, and baseline results (2009) (91)
Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patients (2018) (90)
Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia. (2006) (83)
RESULTS AT AGE 8 YEARS OF EARLY INTERVENTION FOR LOW-BIRTH-WEIGHT PREMATURE INFANTS : THE INFANT HEALTH AND DEVELOPMENT PROGRAM (1997) (74)
Beyond CONSORT: need for improved reporting standards for clinical trials. Consolidated Standards of Reporting Trials. (1998) (70)
Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. (2006) (68)
Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. (1995) (68)
Content of reports on clinical trials: a critical review. (1984) (64)
Double placebo design in a prevention trial for Alzheimer's disease. (2002) (63)
The UGDP Controversy: thirty-four years of contentious ambiguity laid to rest (2004) (63)
Data integrity. (2020) (62)
Gender representation in trials. (2000) (61)
Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. (2006) (60)
Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection. (2014) (56)
Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial (2014) (55)
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. (1997) (54)
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS‐2)? (2011) (54)
Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. (2004) (54)
Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors. (2010) (54)
Clinical Trials Dictionary: Terminology and Usage Recommendations (1996) (54)
Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. (2000) (53)
Citalopram for agitation in Alzheimer’s disease: Design and methods (2012) (52)
Meta-analysis: science or religion? (1989) (52)
Masked monitoring in clinical trials--blind stupidity? (1998) (50)
Mortality in Hepatitis C Virus–Infected Patients With a Diagnosis of AIDS in the Era of Combination Antiretroviral Therapy (2012) (49)
Infant stimulation curriculum for infants with cerebral palsy: effects on infant temperament, parent-infant interaction, and home environment. (1990) (48)
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease. (2012) (48)
Toward prospective registration of clinical trials. (1988) (47)
Interviewer versus self-administered health-related quality of life questionnaires - Does it matter? (2011) (45)
Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: The foscarnet-ganciclovir cytomegalovirus retinitis trial (1997) (43)
Recruitment of participants in the childhood Asthma Management Program (CAMP). I. Description of methods: Childhood Asthma Management Program Research Group. (1999) (42)
Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: The cytomegalovirus retreatment trial (1996) (41)
Identification of meta-analyses. The need for standard terminology. (1990) (41)
Clinical application of operationalized criteria for ‘Depression of Alzheimer's Disease’ (2005) (39)
Design of Depression in Alzheimer's Disease Study-2. (2006) (36)
Correlates of Hypertension in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy (2013) (36)
Factors affecting attrition in a longitudinal study of patients with AIDS (2006) (36)
Cigarette smoking as a risk factor in men with a prior history of myocardial infarction. The Coronary Drug Project Research Group. (1979) (35)
The UGDP Controversy: Clinical Trials Versus Clinical Impressions (1972) (35)
Chronic disease long-term drug prevention trials: Lessons from the Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT) (2008) (34)
J and K (2012) (34)
Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. (2007) (30)
Characteristics and trends of clinical trials funded by the National Institutes of Health between 2005 and 2015 (2017) (27)
Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial. (2006) (27)
Clinical trials and treatment effects monitoring. (1998) (27)
Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group. (2000) (25)
Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease. (2015) (25)
Sample size and power estimates (1986) (24)
Randomization and the mechanics of treatment masking (1986) (23)
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial (2015) (23)
Estimation of gender bias in clinical trials (2001) (22)
Design, methods, and rationale in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group. (1989) (21)
Toward more definitive clinical trials. (1980) (21)
Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019 (2020) (21)
Terminology--a plea for standardization. (1980) (18)
On the detection of outlier clinics in medical and surgical trials: II. Theoretical considerations. (1981) (17)
Organization of multicenter clinical trials. (1981) (16)
Sertraline for the Treatment of Depression in Alzheimer Disease: Genetic Influences (2011) (14)
Treatment effects monitoring committees and early stopping in large clinical trials (2004) (14)
The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen (2006) (14)
Role and methods of the coordinating center (1983) (13)
Format-independent data collection forms. (1995) (13)
Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2. (2014) (13)
Clinical trials: the gold standard for evaluation of therapy. (1996) (13)
Presentation in relation to publication of results from clinical trials. (2007) (13)
Evidence gaps and ethical review of multicenter studies (2015) (12)
Extracorporeal membrane oxygenation trials. (1990) (12)
Clinical Trials Dictionary: Terminology and Usage Recommendations, Second Edition (2012) (12)
Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial. (2003) (12)
Is adjustment of National Eye Institute Visual Function Questionnaire scores for general health necessary in randomized trials? (2004) (12)
Enrollment of women in cardiovascular clinical trials. (2000) (11)
Toward prospective registration of clinical trials. (1988) (11)
In defense of the corporate author for multicenter trials. (1993) (11)
Redesign of trials under different enrollment mixes. (1999) (10)
ADAPT trial data. (2007) (10)
Funding for clinical trials. (1982) (10)
Clinical Trials Handbook: Design and Conduct (2012) (10)
Argon Laser Photocoagulation For Macular Edema In Branch Vein Occlusion. (2018) (9)
Single-center versus multicenter trials (1986) (9)
THE RELATIONSHIP OF TREATMENT TO WEIGHT IN A RANDOMIZED STUDY OF MATURITY‐ONSET DIABETES * (1968) (9)
Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients. (2001) (9)
Study of Familial Patterns of Reported Diabetes: Evaluation of Questionnaire Data (1967) (9)
Comments on NIH clinical trials valid analysis requirement. (1995) (8)
Impact of clinical trials on the practice of medicine (1986) (8)
Clinical trials and data integrity. (1980) (8)
NIH multicenter investigator-initiated trials: an endangered species? (1988) (7)
Risk factors for publications bias: Results of a follow-up study (1990) (7)
On the detection of outlier clinics in medical and surgical trials: I. Practical considerations. (1981) (7)
The status of clinical trials: Cause for concern (2010) (6)
Essential design features of a controlled clinical trial (1986) (6)
Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis (2002) (6)
Patient recruitment and enrollment (1986) (6)
Interim data analyses for treatment monitoring (1986) (6)
Standardization of the Oral Glucose Tolerance Test: Criticisms and Suggestions Invited (1972) (5)
The Cross Trial Safety Analysis (2008) (5)
X, Y, and Z (2012) (5)
The transitioning from trials to extended follow-up studies (2014) (5)
Steering Committee Members (2012) (4)
Why another journal (1980) (4)
Methodology: The case for improved communications (1979) (4)
Follow-up of trials funded by NIH in 1979: Evidence of publication bias (1991) (4)
Why Public Comments Matter: The Case of the National Institutes of Health Policy on Single Institutional Review Board Review of Multicenter Studies (2018) (4)
Clinical Trials, Overview (2005) (4)
Patient notification and follow-up after suspension of treatment protocols. experience from four clinical trials of treatments for AIDS-related CMV retinitis. (2001) (4)
A plea for a discipline of health and medical evaluation. (1975) (4)
Patient follow-up, close-out, and post-trial follow-up (1986) (4)
Multicenter trials and travel: luxury or necessity? (1990) (4)
The trials and tribulations of the University Group Diabetes Program 1: the trial and the controversies (2019) (4)
The study plan (1986) (4)
Policy on Conflicts of Interest (2012) (3)
Long-term drug prevention trials (2008) (3)
CEREBRAL PALSY IN MINNESOTA. STUDY OF PATIENT CARE AND PATIENT NEEDS. (1964) (3)
Does Poly-N-Acetyl Glucosamine Patch Use Reduce Arteriovenous Fistula and Graft Failure Rates in Hemodialysis Patients With End-Stage Renal Disease? (2009) (3)
Clinical trials for implant dentistry: why not? (1990) (3)
IRBs and randomized clinical trials. (1998) (3)
Data collection considerations (1986) (3)
Clinical trials handbook (2017) (3)
Cidofovir for Cytomegalovirus Retinitis: Reply (1997) (3)
Do we need to adjudicate major clinical events? (2008) (3)
44A Treatment effects monitoring practices as viewed through the published literature (1995) (3)
Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis. (2002) (3)
Linear regression analysis of binary response data with mixed covariates - a simulation study. (1984) (3)
Loss to Followup (2012) (3)
The analysis database (1986) (3)
95P On the likelihood of finding subgroup differences in clinical trials (1994) (3)
The trials and tribulations of the University Group Diabetes Program 2: lessons and reflections (2019) (3)
When and how to stop a clinical trial (1979) (2)
46A Gender bias in clinical trials (1994) (2)
Data Processing Procedures (2012) (2)
EPIDURAL AND GENERAL ANESTHESIA ARE ASSOCIATED WITH SIMILAR RATES OF PERIOPERATIVE CARDIAC MORBIDITY AND ISCHEMIA AFTER PERIPHERAL VASCULAR SURGERY (1992) (2)
Gender indexing in publications of clinical trials: 1991-2008 (2010) (2)
Visual Acuity Loss Among Patients With AIDS and CMV Retinitis in the Era of Highly Active Antiretroviral Therapy (HAART) (2006) (2)
Coordinating and other resource centers in multicenter trials (1986) (2)
Questions concerning the design, analysis, and interpretation of clinical trials (1986) (2)
Publication Bias and the Editorial Process-Reply (1992) (2)
Evaluation of hepatitis C virus as a risk factor for HIV-associated neuroretinal disorder. (2013) (2)
An Insider's Guide to Clinical Trials (2011) (2)
Cerebral Palsy in Minnesota. Method of Study, Prevalence, and Distribution—Part I (1961) (2)
Cost and related issues (1986) (1)
Sample Size: Calculation (2012) (1)
Comprar An Insider's Guide to Clinical Trials | Curtis L Meinert | 9780199742967 | Oxford University Press (2011) (1)
Frequentist vs. Bayesian Analysis (2012) (1)
Issues in the organization of reading centers in multicentered clinical trials (1986) (1)
Results of the Early Intervention Program for Low Birth Weight Premature Infants. The Infant Health and Development Program (1997) (1)
Counting and Analysis Rules (2012) (1)
Data analysis requirements and procedures (1986) (1)
Discussion: M K B Parmar and David Machin, monitoring clinical trials; Experience of, and proposals under consideration by the Cancer Therapy Committee of the British Medical Research Council (1993) (1)
The Hypertension Prevention Trial-Reply (1990) (1)
The journal after 10 years (1990) (1)
An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy. (1996) (1)
Update on the clinical trial landscape: analysis of ClinicalTrials.gov registration data, 2000–2020 (2022) (1)
The trialist, meta-analyst, and journal editor: lessons from ADAPT. (2007) (1)
FAREWELL SWAN SONG (1994) (1)
Cerebral palsy in Minnesota. (1961) (1)
Discussion: Frank W Rockhold and G Enas, data monitoring and interim analyses in the pharmaceutical industry: Ethical and logistical considerations: George W Williams et al, monitoring of clinical trials and interim analyses from a drug sponsor's point of view (1993) (1)
Assurances and Certifications (2012) (1)
Preparation of the study publication (1986) (1)
CIDOFOVIR FOR CYTOMEGALOVIRUS RETINITIS. AUTHORS' REPLY (1997) (1)
Committee structures of multicenter trials (1986) (1)
Large (But Simple) Trials: When Are They Justified (1981) (0)
Stopping Rules and Guidelines (2012) (0)
Committee Rules and Procedures (2012) (0)
The laser step in early glaucoma. (1992) (0)
Treatment Effects Monitoring: Approach (2012) (0)
A31 Representation of women and minorities in published clinical trials (1993) (0)
Treatment Effects Monitoring Committee: Questions and Answers (2012) (0)
Clinical trials: A state-of-the-art assessment (1986) (0)
Policy on Payment of Patient‐Related Travel Expenses (2012) (0)
The UGDP Story The UGDP was the brainchild of Max Miller of Case Western Reserve (2004) (0)
Study Chair/Vice‐Chair (2012) (0)
Treatment Compliance Measures (2012) (0)
Randomization: Complete vs. Restricted (2012) (0)
Regulation of Trials (2011) (0)
Controlled Clinical Trials (2005) (0)
Treatment Effects Monitoring: Masking (2012) (0)
Time Window Specifications (2012) (0)
Erratum: Sertraline for the treatment of depression in Alzheimer disease: Genetic influences (Journal of Geriatric Psychiatry and Neurology (2011) 24:4 (222-228) DOI: 10.1177/0891988711422527) (2012) (0)
Policy on Patient‐Care‐Related Payments (2012) (0)
Research Group/Investigators (2012) (0)
Critics and Criticisms (2011) (0)
26 th Annual Meeting of the Society for Clinical Trials Full Conference (2005) (0)
Site Visiting Procedures (2012) (0)
Locating and reading published reports (1986) (0)
Multicenter Trial: Background and Examples† (2014) (0)
Data Entry Design (2012) (0)
Policy on Access to Study Data and Results (2012) (0)
45. Multicenter Trials (2014) (0)
Critical Event Path Analysis (2012) (0)
Ancillary Study Policy (2012) (0)
Policy on Incentive Payments (2012) (0)
Advantages and disadvantages of treatment preference designs for clinical trials (1991) (0)
Required Approvals, Permissions, Accesses, and Supplies (2012) (0)
The Stages of Trials (2011) (0)
A21 Principles of agreement for post NDA clinical trials (1993) (0)
Data Sharing: Internal (2012) (0)
Identifying published reports of clinical trials (1981) (0)
Analysis Questions Regarding Study Results Publications (2012) (0)
Is sertraline treatment or depression remission in depressed Alzheimer’s patients associated with improved caregiver wellbeing? The Depression in Alzheimer’s Disease Study 2 (DIADS-2) (2014) (0)
Study publication and information policies (1986) (0)
Authorship and Credits (2011) (0)
Consent: Disclaimers and Notifications (2012) (0)
Exclusions from Enrollment (2012) (0)
Executive Committee Members (2012) (0)
Treatment Effects Monitoring: Purpose (2012) (0)
Fixed vs. Sequential Sample Size Designs (2012) (0)
The impact of legislative changes on acquired immunodeficiency syndrome drug development (1998) (0)
Sample Size: Design (2012) (0)
Myths Regarding Trials (2011) (0)
Assignment Methods: Fixed vs. Adaptive (2012) (0)
Variance Control Procedures (2012) (0)
Study History Log (2012) (0)
FDA Censoring of Manufacturers' Postmarketing Commitments in HIV/AIDS Drug Approval Letters (2000) (0)
Examination/Clinic Visit Schedule (2012) (0)
Clinic Staffing Requirements (2012) (0)
Eligibility and Exclusions by Reason (2012) (0)
Tricks of the Trade from a Cynic (2011) (0)
Consent: Questions and Answers (2012) (0)
Subgroup Analysis vs. Data Dredging (2011) (0)
Meta-analyses and Systematic Reviews (2011) (0)
Reading Between the Lines, or How to Read a Journal Article (2011) (0)
Crisis management: A coordinating center's experience with the suspension of a aids treatment protocol for a clinical trial (1992) (0)
The evolution of Data and Safety Monitoring Boards (2022) (0)
Treatment Effects Monitoring (2012) (0)
Essential management functions and responsibilities (1986) (0)
Reflections on Carl Kupfer (1928–2011) (2011) (0)
The Anatomy of Trials (2011) (0)
Sample Size: Specifications (2012) (0)
76. UGDP Trial (2014) (0)
Multi‐Study Umbrella Name (2012) (0)
The Recipe for Trials (2011) (0)
Risk of Loss of Visual Acuity for Patients With AIDS (2006) (0)
Type of Funding Initiative (2012) (0)
Design and Flow Schematics (2012) (0)
Policy on Access to Study Documents (2012) (0)
A Perspective on the Process of Designing and Conducting Clinical Trials (2019) (0)
Unmasking Treatment Assignment (2012) (0)
Funding the trial (1986) (0)
Paper Writing (2020) (0)
Consent: Principles and Purpose (2012) (0)
Commentarystatus of clinical trials: Cause for concern (2010) (0)
Drug Masking Procedure (2012) (0)
Archiving Records and Materials (2021) (0)
Treatment Effects Monitoring Committee (2012) (0)
The Coronary Drug Project. Role and methods of the Coordinating Center. (1983) (0)
Data Sharing: External (2012) (0)
47A The clinical research enterprise of the united States as seen through the published literature in relation to gender (1994) (0)
Standing and Working Committees (2012) (0)
Principles and Practices of Controlled Clinical Trials (1981) (0)
IRBs: Models and Procedures (2012) (0)
Quality Control and Assurance Procedures (2012) (0)
Fiscal administration of clinics by coordinating centers: A survey of multicenter eye trials (1992) (0)
Treatment Assignment: Random vs. Nonrandom (2012) (0)
90P Patient characteristics in phase I and II cancer trials (1994) (0)
Fixed vs. Adaptive Designs (2012) (0)
Key Study Documents (2012) (0)
Data Collection: Schedules and Procedures (2012) (0)
What to Make of Results (2011) (0)
Control/Comparison Treatment (2012) (0)
Preparatory steps in executing the study plan (1986) (0)
Design and Operating Principles (2012) (0)
Prevention Trials (2011) (0)
Appendix 2: Sample Design Slide Sets (2012) (0)
Landmark Events and Dates (2012) (0)
Shopping for a Trial (2011) (0)
Policy on Advertising for Patients (2012) (0)
Appendix 1: Design Summaries for Selected Finished Trials (2012) (0)
Mask/masking: Definitions (2012) (0)
Steering Committee Representation Models (2012) (0)
The US requirement to deposit trial data within a year is unworkable (2013) (0)
Bias Control Procedures (2012) (0)
The Nature of Trials (2011) (0)
Appendix 3: Template Summary Worksheet (2012) (0)
Clinical Trials and Our Health (2011) (0)
Steering Committee: Questions, Answers, and Observations (2012) (0)
EffectofCitalopramonAgitationinAlzheimerDisease The CitAD Randomized Clinical Trial (2014) (0)
The Language of Clinical Trials (2011) (0)
Communications: Should mechanisms be established for sharing among clinical trial investigators experiences in handling problems in design, execution, and analysis? Methodology: the case for improved communications. (1979) (0)
Cytomegalovirus Retinitis Incidence in the Highly Active Antiretroviral Therapy (HAART) Era (2011) (0)
The Ethics of Trials (2011) (0)
Treatment Effects Monitoring: Questions and Answers (2012) (0)
Designed Subgroup Comparisons (2012) (0)
Terminology: Conventions and Recommendations (2020) (0)
Masking, Censoring, and Shielding Specifications (2012) (0)
Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration (2004) (0)
Adverse Event Reporting Procedures (2012) (0)
Form Design: Principles and Procedures (2012) (0)
Drug Packaging and Labeling (2012) (0)
The activities of a clinical trial (1986) (0)
Study Name, Authorship, Titling, and Credits (2020) (0)

This paper list is powered by the following services:

Other Resources About Curtis L. Meinert

en.wikipedia.org

What Schools Are Affiliated With Curtis L. Meinert?

Curtis L. Meinert is affiliated with the following schools:

Curtis L. Meinert's Academic­Influence.com Rankings

Curtis L. Meinert's Degrees

Why Is Curtis L. Meinert Influential?

Curtis L. Meinert's Published Works

Published Works

Other Resources About Curtis L. Meinert

What Schools Are Affiliated With Curtis L. Meinert?

Curtis L. Meinert's AcademicInfluence.com Rankings